Hong Kong Stock Movement | IMPACT Therapeutics-B (07630.HK) rises over 15% against the market trend; Senaparib receives EU approval for first-line maintenance treatment of ovarian cancer in the all-comer population

date
19/11/2026
Zhitong Finance APP has learned that IMPACT Therapeutics-B (07630.HK) rose more than 15% against the market trend. As of press time, it was up 11.85% at HK$9.295, with a turnover of HK$53.443 million.